Cargando…

Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma

BACKGROUND: The purpose of this study was to evaluate the potential value of circulating miRNA-122a and miRNA-221 in the diagnosis of hepatocellular carcinoma. METHODS: Serum samples were obtained from 85 patients with hepatocellular carcinoma and 85 age-matched and sex-matched healthy volunteers. m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Jie, Chen, Ming, Huang, Hengliu, Yuan, Tao, Zhang, Mingxu, Zhang, Kejun, Deng, Shaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666878/ https://www.ncbi.nlm.nih.gov/pubmed/23723713 http://dx.doi.org/10.2147/OTT.S44215

Ejemplares similares

Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis
por: Zhao, Xiao-Fei, et al.
Publicado: (2020)

Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma
por: Dhayat, Sameer A., et al.
Publicado: (2015)

Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
por: Wu, Xiaochang, et al.
Publicado: (2022)

Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC)
por: Shehab-Eldeen, Somaia, et al.
Publicado: (2019)

Circulating microRNAs (miR‐16, miR‐22, miR‐122) expression and early diagnosis of hepatocellular carcinoma
por: Fang, Yujia, et al.
Publicado: (2022)

Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
por: Chun, Kwang-Hoon
Publicado: (2022)

The Predictive Efficacy of Serum Exosomal microRNA-122 and microRNA-148a for Hepatocellular Carcinoma Based on Smart Healthcare
por: Deng, Peng, et al.
Publicado: (2022)

Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma
por: Liao, Ling, et al.
Publicado: (2023)

Identification Of Novel lncRNAs For Detection Of HBV-Associated Hepatocellular Carcinoma
por: Li, Yuwei, et al.
Publicado: (2019)

MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
por: Wang, Xiaofei, et al.
Publicado: (2022)

Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus
por: Luo, Jie, et al.
Publicado: (2015)

Imbalance of Th17 and Treg in peripheral blood mononuclear cells of active tuberculosis patients
por: Luo, Jie, et al.
Publicado: (2016)

Circulating microRNA-122 as Potential Biomarker for Detection of Testosterone Abuse
por: Salamin, Olivier, et al.
Publicado: (2016)

Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions
por: Wang, Yu-Long, et al.
Publicado: (2018)

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
por: Burchard, Julja, et al.
Publicado: (2010)

A Novel lncRNA NONHSAT053785 Acts as an Independent Risk Factor for Intrahepatic Metastasis of Hepatocellular Carcinoma
por: Li, Yuwei, et al.
Publicado: (2020)

Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells
por: He, Jialin, et al.
Publicado: (2015)

Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Chen, Xia, et al.
Publicado: (2020)

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Serum exosomal microRNAs combined with alpha‐fetoprotein as diagnostic markers of hepatocellular carcinoma
por: Wang, Yurong, et al.
Publicado: (2018)

Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
por: Hou, Jinpao, et al.
Publicado: (2016)

Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism
por: MacKenzie, Scott M., et al.
Publicado: (2021)

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2021)

MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma
por: Hassan, Marwa, et al.
Publicado: (2022)

Bioinformatics analysis of gene expression alterations in microRNA-122 knockout mice with hepatocellular carcinoma
por: He, Bosheng, et al.
Publicado: (2017)

Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3
por: Ullah, Amin, et al.
Publicado: (2022)

[Retracted] MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2023)

MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review
por: Wei, Xiao-yu, et al.
Publicado: (2020)

MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA
por: Wang, Sheng-Chun, et al.
Publicado: (2014)

Association of circulating microRNA‐122 and microRNA‐29a with stage of fibrosis and progression of chronic hepatitis in Labrador Retrievers
por: Sakai, Manabu, et al.
Publicado: (2018)

Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors
por: Franck, Martin, et al.
Publicado: (2020)

MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma
por: El Mahdy, Hussein Ahmed, et al.
Publicado: (2019)

Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Liver-specific microRNA-122: Biogenesis and function
por: Jopling, Catherine
Publicado: (2012)

Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes
por: Willeit, Peter, et al.
Publicado: (2017)

Circulating MicroRNA‐122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLD
por: Akuta, Norio, et al.
Publicado: (2019)

Diagnostic implication of a circulating serum-based three-microRNA signature in hepatocellular carcinoma
por: Yousuf, Tahira, et al.
Publicado: (2022)

MicroRNA-122: A Novel Hepatocyte-Enriched in vitro Marker of Drug-Induced Cellular Toxicity
por: Kia, Richard, et al.
Publicado: (2015)

MicroRNA-21 as a diagnostic marker for hepatocellular carcinoma: A systematic review and meta-analysis
por: Qu, Juan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lbotcf92c3mmmfmp8fgkvu1u38